Texas Industries’ Subsidiary Restarts Hunter Cement Plant Expansion

Texas Industries, Inc. (NYSE:TXI) today announced that its Texas subsidiary has resumed the Hunter cement plant expansion project near New Braunfels, Texas.

In January of 2009, TXI announced that it was delaying construction on the project due to the downturn in Texas construction activity and accompanying decline in cement demand. Successful cost-reduction and efficiency improvement measures taken by the company over the past two years have enabled TXI to resume construction on the state-of-the-art kiln line in central Texas.

"The hard work accomplished by our employees during these challenging times has afforded us the opportunity to re-start construction at Hunter Cement," shared J. Lynn Davis, Vice President – Cement.

The project is currently about 85% complete, with most of the equipment purchased and at the site. The general contractor, Irondale Industrial Contractors, has begun preliminary mobilization of equipment to resume the project. The new kiln line is expected to begin commissioning within 24 months of the restart of construction.

"Texas continues to be one of the fastest-growing states in the country, and as favorable market conditions begin to return, TXI should be positioned to supply that growth with low-cost and highly efficient capacity," Davis added.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.